# The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.

> **NCT03532802** · PHASE2 · COMPLETED · sponsor: **Steen Hvitfeldt Poulsen** · enrollment: 30 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Metoprolol Succinate
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03532802
- **Lead sponsor:** Steen Hvitfeldt Poulsen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532802, "The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03532802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*